1Becker JC,Dummer R,Hartmann AA,et al.Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α.Journal of Immunology,1999,147: 4398～4401.
2张之南,沈悌.血液病诊断及疗效标准.第2版.天津:天津科学技术出版社,1998,168-194.
3Bruserud O,Ulvestad E.Expression and release of adhesion molecules by human acute myelogenous leukemia blasts.Leuk-Res,1999,23 (2): 149～157.
3Poulaki V,Mitsiades CS,Mitsiades N.The role of Fas and FasL as mediators of anticancer chemotherapy.Drug Resist Updat,2001,4:233-242.
4Wang X,Clowes C,Duarte R,et al.Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.Int J Oncol,2000,17:591-595.
5O' Connell J,Bennett MW,O' Sullivan GC,et al.The Fas counterattack:cancer as a site of immune privilege.Immunol Today,1999,20:46-52.
6Restifo NP.Not so Fas:Re-evaluating the mechanisms of immune privilege and tumor escape.Nat Med,2000,6:493-495.
7Moller P,Henne C,Leithauser F,et al.Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas.Blood,1993,81:2067-2075.
8Wang J,Lenardo MJ.Essential lymphocyte function associated 1 (LFA-1):intercellular adhesion molecule interactions for T cell-mediated B cell apoptosis by Fas/APO-1/CD95.J Exp Med.1997,186:1171-1176.
9Zhou YW,Komada Y,Inaba H,et al.Functional significance of adhesion molecules in Fas-dependent apoptotic cell death induced by interleukin-2 -activated T cells.Immunol Invest,1998,27:309 -322.
10Liu K,Caldwell SA,Abrams SI.Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency.Cancer Res,2005,65:1045-1054.
